ELVN

Enliven Therapeutics, Inc.

NasdaqAdd to watchlist

Healthcare · Biotechnology

$57.45

−$1.92−3.23%

Delayed · 2026-09-09T20:00:00.000Z · marketstack

Aug 10, 2026$57.45

−$1.97−3.32%over 1M

Day range6% of range

$57.29$59.96

Session

Previous close: $59.37
Open: $59.05
Volume: 1.29M
Avg volume: -
Day high: $59.96
Day low: $57.29

Fundamentals

Visualize fundamentals and more

Market cap: 3.8B
P/E ratio: -
EPS (TTM): -$1.60
Dividend yield: -
Beta: 0.23
Shares outstanding: 66.17M

Source SEC EDGAR · 9/10/2026

Risk factors, year on year

Item 1AMarch 2026 10-KMarch 2025as filed.

added: 54
dropped: 57
re-drafted: 59

Out of 262 passages in this year’s Item 1A.

New this year

• We may be required by regulatory authorities to develop and obtain approval for a companion diagnostic in connection with the approval of our product candidate, which could result in additional costs, delays, or failure to obtain approval in certain …

110 more passages, included withBespoke

Recent activity

Mar 25Collins Helen Louise sold 40,000 sharesInsider tradingForm 4CHIEF MEDICAL OFFICER, about $1.4M, pre-planned (10b5-1)
Feb 17Collins Helen Louise sold 45,000 sharesInsider tradingForm 4CHIEF MEDICAL OFFICER, about $1.2M, pre-planned (10b5-1)

2 more events, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like Enliven Therapeutics, Inc.

Also filed under Biotechnology, ranked by how closely they sit beside ELVN.

MRNAModerna, Inc.
ALNYALNYLAM PHARMACEUTICALS, INC.
REGNREGENERON PHARMACEUTICALS, INC.
VRTXVERTEX PHARMACEUTICALS INC / MA
INSMINSMED Inc
ARGXARGENX SE

Ask about Enliven Therapeutics, Inc.

The assistant answers from what ELVN has actually filed: 7 annual reports filed with the SEC, 102 Form 4 filings from the last year and 3 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from ELVN's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding Enliven Therapeutics, Inc., and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with Enliven Therapeutics, Inc.

Separate the decisions from the paperwork
Every Form 4 ELVN insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about Enliven Therapeutics, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.